DE69133077D1 - Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung - Google Patents

Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung

Info

Publication number
DE69133077D1
DE69133077D1 DE69133077T DE69133077T DE69133077D1 DE 69133077 D1 DE69133077 D1 DE 69133077D1 DE 69133077 T DE69133077 T DE 69133077T DE 69133077 T DE69133077 T DE 69133077T DE 69133077 D1 DE69133077 D1 DE 69133077D1
Authority
DE
Germany
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
topical use
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69133077T
Other languages
English (en)
Other versions
DE69133077T2 (de
Inventor
Alfred Moo-Young
Ana Zepeda-Ortega
Horacio Bruno Croxatto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of DE69133077D1 publication Critical patent/DE69133077D1/de
Publication of DE69133077T2 publication Critical patent/DE69133077T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69133077T 1990-06-01 1991-05-24 Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung Expired - Lifetime DE69133077T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53221590A 1990-06-01 1990-06-01

Publications (2)

Publication Number Publication Date
DE69133077D1 true DE69133077D1 (de) 2002-08-29
DE69133077T2 DE69133077T2 (de) 2002-11-07

Family

ID=24120850

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69125855T Expired - Lifetime DE69125855T2 (de) 1990-06-01 1991-05-24 Therapeutisch wirksame, örtliche anwendung von st1435
DE69133077T Expired - Lifetime DE69133077T2 (de) 1990-06-01 1991-05-24 Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69125855T Expired - Lifetime DE69125855T2 (de) 1990-06-01 1991-05-24 Therapeutisch wirksame, örtliche anwendung von st1435

Country Status (10)

Country Link
US (1) US5651973A (de)
EP (3) EP1093816A3 (de)
JP (1) JP2625254B2 (de)
AT (2) ATE151977T1 (de)
CA (1) CA2083404C (de)
DE (2) DE69125855T2 (de)
DK (2) DK0754456T3 (de)
ES (2) ES2180690T3 (de)
GR (1) GR3023312T3 (de)
WO (1) WO1991018570A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180690T3 (es) * 1990-06-01 2003-02-16 Population Council Inc Preparacion de composiciones que comprenden st1435 para aplicacion topica.
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US8529807B2 (en) * 2002-01-17 2013-09-10 Lts Lohmann Therapie-Systeme Ag Method for neutralizing or recycling carrier materials for film-like coatings
GB2389793A (en) * 2002-06-18 2003-12-24 Euro Celtique Sa Transdermal delivery system
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
US20110220817A1 (en) * 2008-08-12 2011-09-15 Moore John W Method of reducing the distortion of the electromagnetic field
JP6082249B2 (ja) 2009-12-17 2017-02-15 ザ・ポピュレイション・カウンシル，インコーポレイテッド 経皮ゲル製剤
US10322063B2 (en) 2013-03-19 2019-06-18 Genovus Biotechnologies Inc. Muscle optimization device and method
US10888707B2 (en) 2013-03-19 2021-01-12 Genovus Biotechnologies Inc. Muscle optimization device and method
CN107429201B (zh) 2014-11-25 2020-10-16 巴克曼实验室国际公司 毛毡调理剂和清洁剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543245C3 (de) * 1965-11-26 1974-07-18 Merck Patent Gmbh, 6100 Darmstadt 16-Methy len-19-norprogesteronderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
NL6902314A (de) * 1969-02-13 1970-08-17
US3948262A (en) * 1969-04-01 1976-04-06 Alza Corporation Novel drug delivery device
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
US4818540A (en) * 1985-02-25 1989-04-04 Rutgers, The State University Of New Jersey Transdermal fertility control system and process
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
WO1991018572A1 (en) * 1990-06-01 1991-12-12 Robertson, Dale, N. Device for transdermal administration of drugs
ES2180690T3 (es) * 1990-06-01 2003-02-16 Population Council Inc Preparacion de composiciones que comprenden st1435 para aplicacion topica.
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
EP0600873A4 (de) 1993-09-02
CA2083404C (en) 2001-02-20
EP0754456A3 (de) 2000-02-02
CA2083404A1 (en) 1991-12-02
DE69133077T2 (de) 2002-11-07
WO1991018570A1 (en) 1991-12-12
DE69125855T2 (de) 1997-07-31
ATE220912T1 (de) 2002-08-15
DE69125855D1 (de) 1997-05-28
GR3023312T3 (en) 1997-08-29
ES2180690T3 (es) 2003-02-16
EP0754456A2 (de) 1997-01-22
JPH07502253A (ja) 1995-03-09
EP1093816A2 (de) 2001-04-25
US5651973A (en) 1997-07-29
EP0600873B1 (de) 1997-04-23
EP1093816A3 (de) 2003-10-22
EP0754456B1 (de) 2002-07-24
ATE151977T1 (de) 1997-05-15
EP0600873A1 (de) 1994-06-15
DK0754456T3 (da) 2002-11-11
ES2099747T3 (es) 1997-06-01
DK0600873T3 (da) 1997-05-20
JP2625254B2 (ja) 1997-07-02

Similar Documents

Publication Publication Date Title
DE3872372D1 (de) Zusammensetzung zur erhoehung der intrazell-atp-spiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
SE8406538D0 (sv) Novel derivatives of purine
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
ES2173858T3 (es) Analogos de huperzina a.
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
DK0951553T3 (da) Adenovirus-E4-proteiner til induktion af celledød
DE69111974D1 (de) Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum.
IE780497L (en) Broparestrol based therapeutic compositions
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IT1291307B1 (it) Composizione farmaceutica atta al trattamento delle patologie neurodegenerative
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
NO904611L (no) Farmasoeytiske preparater inneholdende deoksyribonukleosider for saarheling.
GT199200060A (es) Derivados de n-acil-alfa aminoacido
UA37377A (uk) Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: THE POPULATION COUNCIL, INC., NEW YORK, N.Y., US

8364 No opposition during term of opposition